首页 > 最新文献

Journal of Perinatology最新文献

英文 中文
The effect of furosemide on extremely premature infants treated with nonsteroidal anti-inflammatory drugs for persistent patent ductus arteriosus. 呋塞米对使用非甾体抗炎药治疗动脉导管未闭的极早产儿的影响。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-08 DOI: 10.1038/s41372-024-02148-2
Mar Romero-Lopez, Samantha Su, Rafael Bravo, Danielle R Rios, Tina Oak Findley, Covi Anne Tibe, Patrick J McNamara
{"title":"The effect of furosemide on extremely premature infants treated with nonsteroidal anti-inflammatory drugs for persistent patent ductus arteriosus.","authors":"Mar Romero-Lopez, Samantha Su, Rafael Bravo, Danielle R Rios, Tina Oak Findley, Covi Anne Tibe, Patrick J McNamara","doi":"10.1038/s41372-024-02148-2","DOIUrl":"https://doi.org/10.1038/s41372-024-02148-2","url":null,"abstract":"","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternity care practices supportive of breastfeeding in U.S. advanced neonatal care units, United States, 2022 美国高级新生儿护理病房支持母乳喂养的产妇护理措施,美国,2022 年。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-07 DOI: 10.1038/s41372-024-02139-3
E. Anstey, A. Noiman, E. Boundy, J. Nelson
To describe breastfeeding-supportive practices in U.S. maternity hospitals with advanced neonatal care units (ANCU). Using 2022 mPINC data, we calculated the percent of hospitals reporting (1) breastfeeding-supportive practices for “most” (≥80%) mother-baby dyads in ANCUs, by hospital demographic characteristics and (2) infant receipt of mother’s own milk or donor milk at any time while in the ANCU, by ANCU level. More than 90% of hospitals reported that “most” mothers (≥80%) were advised on some breastfeeding-supportive practices. Fewer hospitals reported that “most” mothers expressed milk within one hour of birth (37%) or that kangaroo care was practiced for “most” eligible newborns (63%). Receipt of mother’s own milk varied by unit level and state. Breastfeeding-supportive practices requiring the technical competency of healthcare providers (e.g., early milk expression, kangaroo care) are less likely to be implemented in ANCU settings compared to practices centered around providing advice or education.
研究目的研究设计:利用 2022 年的 mPINC 数据,我们计算了报告以下情况的医院百分比:(1) 按医院人口统计学特征划分,新生儿监护病房中 "大多数"(≥80%)母婴二人组采取了支持母乳喂养的措施;(2) 按新生儿监护病房级别划分,婴儿在新生儿监护病房的任何时候都接受了母亲自己的奶或捐赠奶:结果:90%以上的医院报告说,"大多数 "母亲(≥80%)获得了一些支持母乳喂养做法的建议。较少医院报告 "大多数 "母亲在产后一小时内挤出母乳(37%),或对 "大多数 "符合条件的新生儿实施袋鼠式护理(63%)。接受母亲自己的乳汁的情况因单位级别和州而异:结论:与以提供建议或教育为中心的实践相比,需要医疗服务提供者具备技术能力的母乳喂养支持性实践(如早期挤奶、袋鼠式护理)在产科急诊室环境中实施的可能性较低。
{"title":"Maternity care practices supportive of breastfeeding in U.S. advanced neonatal care units, United States, 2022","authors":"E. Anstey, A. Noiman, E. Boundy, J. Nelson","doi":"10.1038/s41372-024-02139-3","DOIUrl":"10.1038/s41372-024-02139-3","url":null,"abstract":"To describe breastfeeding-supportive practices in U.S. maternity hospitals with advanced neonatal care units (ANCU). Using 2022 mPINC data, we calculated the percent of hospitals reporting (1) breastfeeding-supportive practices for “most” (≥80%) mother-baby dyads in ANCUs, by hospital demographic characteristics and (2) infant receipt of mother’s own milk or donor milk at any time while in the ANCU, by ANCU level. More than 90% of hospitals reported that “most” mothers (≥80%) were advised on some breastfeeding-supportive practices. Fewer hospitals reported that “most” mothers expressed milk within one hour of birth (37%) or that kangaroo care was practiced for “most” eligible newborns (63%). Receipt of mother’s own milk varied by unit level and state. Breastfeeding-supportive practices requiring the technical competency of healthcare providers (e.g., early milk expression, kangaroo care) are less likely to be implemented in ANCU settings compared to practices centered around providing advice or education.","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":"44 11","pages":"1560-1566"},"PeriodicalIF":2.4,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis C infection screening and connection to care among postpartum patients and exposed infants in two community hospitals, 3-year follow-up — Oregon, 2019–2024 两家社区医院产后患者和暴露婴儿的丙型肝炎感染筛查和护理连接,3 年随访 - 俄勒冈州,2019-2024 年。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-05 DOI: 10.1038/s41372-024-02138-4
Genevieve L. Buser, Horia Marginean, Mayen Dada, Savannah Woodward, Alexis Young, Chiayi Chen, Mark W. Tomlinson
Determine prevalence of hepatitis C virus (HCV) positivity among postpartum patients to inform prenatal screening recommendations, postpartum connection to care, and infant HCV screening practices. Convenience sample of postpartum patients at one urban and one suburban hospital to undergo rapid fingerstick testing for hepatitis C antibodies. Of 2060 postpartum participants successfully screened, 20 (0.97%) had evidence of past or current HCV infection. One co-infection with syphilis occurred. After a median follow-up of 3.75 years, 6 of 12 participants (50.0%) with chronic HCV infection completed treatment with cure, and 9 of 20 infants (45.0%) completed screening. One neonatal transmission event occurred (5.8%). HCV infection was more common in our postpartum population than other viral infections routinely screened for during pregnancy. Efforts to decrease perinatal HCV transmission should focus on early postpartum connection to treatment team, early screening in infants aged 2–6 months, and pediatric test completion.
目的:确定产后患者中丙型肝炎病毒 (HCV) 阳性率:确定产后患者丙型肝炎病毒(HCV)阳性率,为产前筛查建议、产后护理连接和婴儿 HCV 筛查做法提供参考:研究设计:对一家市区医院和一家郊区医院的产后患者进行方便抽样,对其进行丙型肝炎抗体快速指针检测:结果:在成功筛查的 2060 名产后参与者中,有 20 人(0.97%)有证据表明过去或现在感染过丙型肝炎病毒。有一人合并梅毒感染。中位随访 3.75 年后,12 名慢性 HCV 感染者中有 6 人(50.0%)完成了治愈治疗,20 名婴儿中有 9 人(45.0%)完成了筛查。发生了一起新生儿传播事件(5.8%):结论:与孕期常规筛查的其他病毒感染相比,HCV 感染在产后人群中更为常见。减少围产期 HCV 传播的工作重点应放在产后早期与治疗团队的联系、2-6 个月婴儿的早期筛查以及完成儿科检测上。
{"title":"Hepatitis C infection screening and connection to care among postpartum patients and exposed infants in two community hospitals, 3-year follow-up — Oregon, 2019–2024","authors":"Genevieve L. Buser, Horia Marginean, Mayen Dada, Savannah Woodward, Alexis Young, Chiayi Chen, Mark W. Tomlinson","doi":"10.1038/s41372-024-02138-4","DOIUrl":"10.1038/s41372-024-02138-4","url":null,"abstract":"Determine prevalence of hepatitis C virus (HCV) positivity among postpartum patients to inform prenatal screening recommendations, postpartum connection to care, and infant HCV screening practices. Convenience sample of postpartum patients at one urban and one suburban hospital to undergo rapid fingerstick testing for hepatitis C antibodies. Of 2060 postpartum participants successfully screened, 20 (0.97%) had evidence of past or current HCV infection. One co-infection with syphilis occurred. After a median follow-up of 3.75 years, 6 of 12 participants (50.0%) with chronic HCV infection completed treatment with cure, and 9 of 20 infants (45.0%) completed screening. One neonatal transmission event occurred (5.8%). HCV infection was more common in our postpartum population than other viral infections routinely screened for during pregnancy. Efforts to decrease perinatal HCV transmission should focus on early postpartum connection to treatment team, early screening in infants aged 2–6 months, and pediatric test completion.","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":"45 1","pages":"122-127"},"PeriodicalIF":2.4,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Success and opportunities of the American Academy of Pediatrics Marshall Klaus research grant program in neonatal-perinatal medicine. 美国儿科学会马歇尔-克劳斯新生儿围产期医学研究补助金计划的成功与机遇。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-05 DOI: 10.1038/s41372-024-02137-5
Albertina Lee, Joern-Hendrik Weitkamp, Angie Tune, Jim Couto, Krithika Lingappan

Background: Physician-scientists are a crucial link between clinical practice and research. The American Academy of Pediatrics (AAP) initiated the Marshall Klaus Perinatal Research Award to enhance the development of research skills among physicians training in Neonatal-Perinatal Medicine.

Methods: In this study, we sought to identify trends in funding along with geographical and demographic variables of the applicants and mentees and assess the applicants' scholarly productivity and funding from the National Institutes of Health (NIH). We reviewed the data of applicants and awardees from 2015-2024.

Results: We found that basic science applications had a higher funding likelihood than clinical/translational applications. The geographical distribution of awardees is skewed. There was a significant association between awardee status and K08 or K23 funding attainment.

Conclusions: Future efforts should support more equitable award distribution and a diverse research landscape in neonatal-perinatal medicine.

背景:医生科学家是临床实践与研究之间的重要纽带。美国儿科学会(AAP)设立了马歇尔-克劳斯围产期研究奖(Marshall Klaus Perinatal Research Award),以提高接受新生儿-围产期医学培训的医生的研究技能:在这项研究中,我们试图确定资助趋势以及申请人和被资助人的地理和人口变量,并评估申请人的学术生产力和美国国立卫生研究院(NIH)的资助情况。我们审查了 2015-2024 年间申请人和获奖者的数据:我们发现,与临床/转化申请相比,基础科学申请获得资助的可能性更高。获奖者的地理分布存在偏差。获奖者身份与获得K08或K23资助之间存在明显关联:结论:未来的努力应支持新生儿围产期医学领域更公平的奖项分配和多样化的研究环境。
{"title":"Success and opportunities of the American Academy of Pediatrics Marshall Klaus research grant program in neonatal-perinatal medicine.","authors":"Albertina Lee, Joern-Hendrik Weitkamp, Angie Tune, Jim Couto, Krithika Lingappan","doi":"10.1038/s41372-024-02137-5","DOIUrl":"https://doi.org/10.1038/s41372-024-02137-5","url":null,"abstract":"<p><strong>Background: </strong>Physician-scientists are a crucial link between clinical practice and research. The American Academy of Pediatrics (AAP) initiated the Marshall Klaus Perinatal Research Award to enhance the development of research skills among physicians training in Neonatal-Perinatal Medicine.</p><p><strong>Methods: </strong>In this study, we sought to identify trends in funding along with geographical and demographic variables of the applicants and mentees and assess the applicants' scholarly productivity and funding from the National Institutes of Health (NIH). We reviewed the data of applicants and awardees from 2015-2024.</p><p><strong>Results: </strong>We found that basic science applications had a higher funding likelihood than clinical/translational applications. The geographical distribution of awardees is skewed. There was a significant association between awardee status and K08 or K23 funding attainment.</p><p><strong>Conclusions: </strong>Future efforts should support more equitable award distribution and a diverse research landscape in neonatal-perinatal medicine.</p>","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142377991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit. 一项旨在减少新生儿重症监护室过量使用吸入疗法的质量改进计划。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1038/s41372-024-02132-w
Avery Zierk, Mary Jo Gumbel, Rachel Mackenzie, Kelle Matthews, Francis Simmons, Anna Bustin, Christina DeFelice, Heidi Morris, Leane Soorikian, Kimberly Swartz, Amanda Nickel, Kathleen Gibbs

Objective: Inhaled medications are commonly used at our single-center, Level IV neonatal intensive care unit (NICU). We lacked a standardized process for measuring efficacy of these medications to guide optimal duration of use, potentially leading to their overuse.

Methods: We utilized quality improvement methodology to reduce the length of inhaled hypertonic saline (HTS) course durations and high frequency albuterol use. Interventions included education, data sharing, and implementation of a respiratory therapy assessment tool.

Results: The average inhaled HTS course duration decreased from 8.7 to 4.2 days. The percentage of q4 albuterol administrations per total albuterol doses administered monthly decreased from 39 to 20%.

Conclusion: Developing a shared mental model between interprofessional providers for the indication and effect of inhaled agents and standardizing assessment of these medications' efficacy can reduce their overuse.

目的:新生儿重症监护病房(NICU)是一家单中心四级新生儿重症监护病房,常用吸入药物。我们缺乏衡量这些药物疗效的标准化流程来指导最佳用药时间,这可能会导致药物的过度使用:我们利用质量改进方法缩短了吸入性高渗盐水(HTS)疗程和高频率使用阿布特罗的时间。干预措施包括教育、数据共享和实施呼吸治疗评估工具:结果:吸入高渗盐水的平均疗程从 8.7 天缩短至 4.2 天。结果:吸入式 HTS 的平均疗程从 8.7 天减少到 4.2 天,q4 阿布特罗用药量占每月阿布特罗总用药量的比例从 39% 减少到 20%:结论:在跨专业医疗服务提供者之间就吸入式药物的适应症和效果建立共同的心理模型,并对这些药物的疗效进行标准化评估,可以减少药物的过度使用。
{"title":"A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit.","authors":"Avery Zierk, Mary Jo Gumbel, Rachel Mackenzie, Kelle Matthews, Francis Simmons, Anna Bustin, Christina DeFelice, Heidi Morris, Leane Soorikian, Kimberly Swartz, Amanda Nickel, Kathleen Gibbs","doi":"10.1038/s41372-024-02132-w","DOIUrl":"https://doi.org/10.1038/s41372-024-02132-w","url":null,"abstract":"<p><strong>Objective: </strong>Inhaled medications are commonly used at our single-center, Level IV neonatal intensive care unit (NICU). We lacked a standardized process for measuring efficacy of these medications to guide optimal duration of use, potentially leading to their overuse.</p><p><strong>Methods: </strong>We utilized quality improvement methodology to reduce the length of inhaled hypertonic saline (HTS) course durations and high frequency albuterol use. Interventions included education, data sharing, and implementation of a respiratory therapy assessment tool.</p><p><strong>Results: </strong>The average inhaled HTS course duration decreased from 8.7 to 4.2 days. The percentage of q4 albuterol administrations per total albuterol doses administered monthly decreased from 39 to 20%.</p><p><strong>Conclusion: </strong>Developing a shared mental model between interprofessional providers for the indication and effect of inhaled agents and standardizing assessment of these medications' efficacy can reduce their overuse.</p>","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic dextrose gel use in newborns at risk for hypoglycemia 在有低血糖风险的新生儿中预防性使用葡萄糖凝胶。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-03 DOI: 10.1038/s41372-024-02133-9
Venkatasai Devarapalli, Makenzie Niven, Jared Canonigo, Beverly Spray, Indirapriya Avulakunta, Jared Beavers, Jennifer Andrews, Vikramaditya Dumpa
To assess the impact of prophylactic dextrose gel on short-term outcomes in infants at risk for hypoglycemia. Retrospective, single-center, observational study of neonates at risk for hypoglycemia -infants of diabetic mothers, large and small for gestational age infants, born between January 2015 and May 2023. Infants were categorized into two groups for analysis. 1. Pre- dextrose gel (01/2015 to 04/2018, n = 788) and 2. Dextrose gel (01/2019 to 05/2023, n = 1495). Infant demographic data and outcome variables were compared between the two groups. 2283 infants were eligible. Prophylactic dextrose gel use was associated with decreased admission rates to NICU secondary to hypoglycemia (2.7% vs. 6.5%), reduced incidence of hypoglycemia (32% vs. 43.3%), and higher exclusive breastmilk use at discharge (47% vs. 37.3%). The use of prophylactic dextrose gel in certain high-risk newborns was associated with improved patient outcomes.
目的:评估预防性葡萄糖凝胶对低血糖风险婴儿短期疗效的影响:评估预防性葡萄糖凝胶对低血糖风险婴儿短期预后的影响:回顾性、单中心、观察性研究,对象为 2015 年 1 月至 2023 年 5 月间出生的有低血糖风险的新生儿--母亲为糖尿病患者的婴儿、胎龄大的婴儿和胎龄小的婴儿。婴儿分为两组进行分析。1.葡萄糖凝胶前(01/2015 至 04/2018,n = 788)和 2.葡萄糖凝胶(01/2019 至 05/2023,n = 1495)。对两组婴儿的人口统计学数据和结果变量进行了比较。使用预防性葡萄糖凝胶可降低因低血糖而入住新生儿重症监护室的比例(2.7% vs. 6.5%),降低低血糖发生率(32% vs. 43.3%),提高出院时纯母乳使用率(47% vs. 37.3%):结论:对某些高风险新生儿使用预防性葡萄糖凝胶可改善患者的预后。
{"title":"Prophylactic dextrose gel use in newborns at risk for hypoglycemia","authors":"Venkatasai Devarapalli,&nbsp;Makenzie Niven,&nbsp;Jared Canonigo,&nbsp;Beverly Spray,&nbsp;Indirapriya Avulakunta,&nbsp;Jared Beavers,&nbsp;Jennifer Andrews,&nbsp;Vikramaditya Dumpa","doi":"10.1038/s41372-024-02133-9","DOIUrl":"10.1038/s41372-024-02133-9","url":null,"abstract":"To assess the impact of prophylactic dextrose gel on short-term outcomes in infants at risk for hypoglycemia. Retrospective, single-center, observational study of neonates at risk for hypoglycemia -infants of diabetic mothers, large and small for gestational age infants, born between January 2015 and May 2023. Infants were categorized into two groups for analysis. 1. Pre- dextrose gel (01/2015 to 04/2018, n = 788) and 2. Dextrose gel (01/2019 to 05/2023, n = 1495). Infant demographic data and outcome variables were compared between the two groups. 2283 infants were eligible. Prophylactic dextrose gel use was associated with decreased admission rates to NICU secondary to hypoglycemia (2.7% vs. 6.5%), reduced incidence of hypoglycemia (32% vs. 43.3%), and higher exclusive breastmilk use at discharge (47% vs. 37.3%). The use of prophylactic dextrose gel in certain high-risk newborns was associated with improved patient outcomes.","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":"44 11","pages":"1640-1646"},"PeriodicalIF":2.4,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of antenatal steroid administration with neonatal morbidities among late preterm multiple gestation infants 晚期早产多胎妊娠婴儿产前服用类固醇与新生儿发病率的关系。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1038/s41372-024-02130-y
Pradeep Kumar Velumula, Praveen Kumar Boddu, Luna Khanal, Sanket Jani, Nithi Fernandes, Ronald Thomas, Monika Bajaj, Sanjay Chawla
There is limited evidence on the efficacy of antenatal steroids (ANS) among women with multiple gestations at risk of late preterm delivery. This retrospective study included multiple gestation, late preterm infants (340/7–366/7 weeks’ gestational age), born between January 2013 and December 2022. The primary outcome was composite respiratory outcome, defined as the need for respiratory support by 72 hours of age. Logistic and linear regressions were performed to compare the primary and secondary outcomes with and without exposure to any ANS, adjusted for gestational age, sex of infant, histologic chorioamnionitis, and intrauterine growth restriction. The composite respiratory outcome was significantly lower in any ANS group compared to no ANS group (28.6% vs. 33.7%) [adjusted odds ratio 0.50, 95% CI, 0.33–0.75, p < 0.001]. In late preterm multiple gestation infants, any ANS exposure was associated with lower risk of composite respiratory outcome.
背景:在有晚期早产风险的多胎妊娠妇女中,产前类固醇(ANS)的疗效证据有限:这项回顾性研究纳入了2013年1月至2022年12月期间出生的多胎妊娠晚期早产儿(胎龄340/7-366/7周)。研究的主要结果是综合呼吸系统结果,即婴儿出生 72 小时后是否需要呼吸支持。在对胎龄、婴儿性别、组织学绒毛膜羊膜炎和宫内生长受限进行调整后,进行了逻辑回归和线性回归,以比较接触和未接触任何抗逆转录病毒药物的主要和次要结果:结果:与不接触任何抗逆转录病毒药物组相比,接触任何抗逆转录病毒药物组的综合呼吸系统结果明显较低(28.6% 对 33.7%)[调整后的几率比 0.50,95% CI,0.33-0.75,p 结论:在晚期早产多胎妊娠中,接触任何抗逆转录病毒药物组的综合呼吸系统结果明显较低(28.6% 对 33.7%):在晚期早产多胎妊娠婴儿中,接触任何抗逆转录病毒药物与较低的呼吸系统综合结局风险相关。
{"title":"Association of antenatal steroid administration with neonatal morbidities among late preterm multiple gestation infants","authors":"Pradeep Kumar Velumula,&nbsp;Praveen Kumar Boddu,&nbsp;Luna Khanal,&nbsp;Sanket Jani,&nbsp;Nithi Fernandes,&nbsp;Ronald Thomas,&nbsp;Monika Bajaj,&nbsp;Sanjay Chawla","doi":"10.1038/s41372-024-02130-y","DOIUrl":"10.1038/s41372-024-02130-y","url":null,"abstract":"There is limited evidence on the efficacy of antenatal steroids (ANS) among women with multiple gestations at risk of late preterm delivery. This retrospective study included multiple gestation, late preterm infants (340/7–366/7 weeks’ gestational age), born between January 2013 and December 2022. The primary outcome was composite respiratory outcome, defined as the need for respiratory support by 72 hours of age. Logistic and linear regressions were performed to compare the primary and secondary outcomes with and without exposure to any ANS, adjusted for gestational age, sex of infant, histologic chorioamnionitis, and intrauterine growth restriction. The composite respiratory outcome was significantly lower in any ANS group compared to no ANS group (28.6% vs. 33.7%) [adjusted odds ratio 0.50, 95% CI, 0.33–0.75, p &lt; 0.001]. In late preterm multiple gestation infants, any ANS exposure was associated with lower risk of composite respiratory outcome.","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":"45 1","pages":"24-29"},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in NICU utilization: a narrative review and path forward. 新生儿重症监护室利用率的变化:回顾与展望。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1038/s41372-024-02129-5
David A Paul, Stephen A Pearlman

Utilization of the Neonatal Intensive Care Unit (NICU) varies widely in the United States. Over recent decades, there has been a growth in NICUs, that varies by region, and has not been correlated to changes in demand or illness severity. Unnecessary NICU admissions are costly, stressful to families, may increase the risk of hospital acquired morbidities, and decrease breast feeding. Most of the variation in NICU utilization is based on the care of late preterm, early term, and term babies and is related to hospital level factors, including financial incentives, driving utilization. Improvement strategies to reduce variation include regionalization of care, certificate of need legislation, improving discharge processes, and caring for babies with some conditions such as Neonatal Opioid Withdrawal Syndrome or those with risk factors for sepsis outside of the NICU.

在美国,新生儿重症监护室(NICU)的使用率差别很大。近几十年来,新生儿重症监护室的数量因地区而异,且与需求或疾病严重程度的变化无关。不必要的新生儿重症监护室住院费用高昂,对家庭造成压力,可能会增加医院获得性疾病的风险,并减少母乳喂养。新生儿重症监护室使用率的大部分差异都是基于早产晚期、足月早期和足月婴儿的护理,并与医院层面的因素(包括经济激励)有关,这些因素推动了新生儿重症监护室的使用率。减少差异的改进策略包括:区域化护理、需求证明立法、改进出院流程以及在新生儿重症监护室外护理患有新生儿阿片类药物戒断综合症等疾病或有脓毒症风险因素的婴儿。
{"title":"Variation in NICU utilization: a narrative review and path forward.","authors":"David A Paul, Stephen A Pearlman","doi":"10.1038/s41372-024-02129-5","DOIUrl":"https://doi.org/10.1038/s41372-024-02129-5","url":null,"abstract":"<p><p>Utilization of the Neonatal Intensive Care Unit (NICU) varies widely in the United States. Over recent decades, there has been a growth in NICUs, that varies by region, and has not been correlated to changes in demand or illness severity. Unnecessary NICU admissions are costly, stressful to families, may increase the risk of hospital acquired morbidities, and decrease breast feeding. Most of the variation in NICU utilization is based on the care of late preterm, early term, and term babies and is related to hospital level factors, including financial incentives, driving utilization. Improvement strategies to reduce variation include regionalization of care, certificate of need legislation, improving discharge processes, and caring for babies with some conditions such as Neonatal Opioid Withdrawal Syndrome or those with risk factors for sepsis outside of the NICU.</p>","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A high-tech wreck: HIPAA roadblocks to texting patients. 高科技车祸给病人发短信的 HIPAA 路障。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-01 DOI: 10.1038/s41372-024-02131-x
Jonathan Fanaroff
{"title":"A high-tech wreck: HIPAA roadblocks to texting patients.","authors":"Jonathan Fanaroff","doi":"10.1038/s41372-024-02131-x","DOIUrl":"https://doi.org/10.1038/s41372-024-02131-x","url":null,"abstract":"","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term neurodevelopmental outcomes at three years in preterm infants born before 29 Weeks gestation following Preterm Premature Rupture of Membranes (PPROM). 妊娠 29 周前出生的早产儿在胎膜早破(PPROM)后 3 年的长期神经发育结果。
IF 2.4 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-30 DOI: 10.1038/s41372-024-02134-8
Harkirat Bhullar, Amelie Stritzke, Sue Makarchuk, Selphee Tang, Abhay Lodha

Objective: To determine the association between preterm premature rupture of membranes (PPROM) and neurodevelopmental impairment (NDI) at 3 years corrected age (CA) in infants born before 29 weeks of gestational age (GA).

Design/methods: Infants born before 29 weeks GA between 2005 and 2017 were included. The primary outcome was a composite of death or NDI (full-scale intelligence quotient<85, cerebral palsy, vision or hearing impairment) at 3 years of CA. Infants were stratified by maternal PPROM status. Associations were explored using multivariate models.

Results: Of 1231 participants, 481 were in the PPROM group, and 750 were in the No PPROM group. After adjusting for factors, the odds ratio of death or NDI for PPROM vs. No PPROM was 1.22 (95% Confidence Interval 0.93-1.59).

Conclusion: Our study suggests that PPROM was not associated with an increased risk of a composite outcome of death or NDI at 3 years CA.

目的确定胎龄(GA)29周前出生的早产胎膜早破(PPROM)与3岁矫正年龄(CA)时神经发育障碍(NDI)之间的关联:纳入2005年至2017年间胎龄29周前出生的婴儿。主要结果是死亡或NDI(全量表智商)的综合结果:在1231名参与者中,481人属于PPROM组,750人属于无PPROM组。在对各种因素进行调整后,PPROM 与无 PPROM 死亡或 NDI 的几率比为 1.22(95% 置信区间为 0.93-1.59):我们的研究表明,PPROM 与 3 年 CA 时死亡或 NDI 综合结果的风险增加无关。
{"title":"Long-term neurodevelopmental outcomes at three years in preterm infants born before 29 Weeks gestation following Preterm Premature Rupture of Membranes (PPROM).","authors":"Harkirat Bhullar, Amelie Stritzke, Sue Makarchuk, Selphee Tang, Abhay Lodha","doi":"10.1038/s41372-024-02134-8","DOIUrl":"https://doi.org/10.1038/s41372-024-02134-8","url":null,"abstract":"<p><strong>Objective: </strong>To determine the association between preterm premature rupture of membranes (PPROM) and neurodevelopmental impairment (NDI) at 3 years corrected age (CA) in infants born before 29 weeks of gestational age (GA).</p><p><strong>Design/methods: </strong>Infants born before 29 weeks GA between 2005 and 2017 were included. The primary outcome was a composite of death or NDI (full-scale intelligence quotient<85, cerebral palsy, vision or hearing impairment) at 3 years of CA. Infants were stratified by maternal PPROM status. Associations were explored using multivariate models.</p><p><strong>Results: </strong>Of 1231 participants, 481 were in the PPROM group, and 750 were in the No PPROM group. After adjusting for factors, the odds ratio of death or NDI for PPROM vs. No PPROM was 1.22 (95% Confidence Interval 0.93-1.59).</p><p><strong>Conclusion: </strong>Our study suggests that PPROM was not associated with an increased risk of a composite outcome of death or NDI at 3 years CA.</p>","PeriodicalId":16690,"journal":{"name":"Journal of Perinatology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142348704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Perinatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1